ATXS icon

Astria Therapeutics
ATXS

Overview Fund Activity

26 hedge funds and large institutions have $23.9M invested in Astria Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
6
Reduced
6
Closed
4
Calls
$6.08M
Puts
–
Net Calls
+$6.08M
Net Calls Change
-$3M

Top Buyers

1
WG
1
Winton Group
United Kingdom
$353K
2
MIM
2
Monashee Investment Management
Massachusetts
$330K
3
OC
3
Oppenheimer & Co
New York
$431K
4
Northern Trust
4
Northern Trust
Illinois
$314K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.28M

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$196K
2
Millennium Management
2
Millennium Management
New York
$0
3
OAM
3
Oxford Asset Management
United Kingdom
$590K
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$173K
5
PAM
5
Panagora Asset Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
26
Fidelity Investments
Massachusetts
$1K 190 +190 New
Millennium Management
27
Millennium Management
New York
– – -21,118 Closed
PAM
28
Panagora Asset Management
Massachusetts
– – -6,727 Closed
UBS Group
29
UBS Group
Switzerland
– – -1,395 Closed
TRCT
30
Tower Research Capital (TRC)
New York
– – -709 Closed
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
Alyeska Investment Group
32
Alyeska Investment Group
Illinois
– – – –
1
2